Literature DB >> 26059246

Factors influencing the process of medication (non-)adherence and (non-)persistence in breast cancer patients with adjuvant antihormonal therapy: a qualitative study.

M Verbrugghe1, S Verhaeghe1, E Decoene2, S De Baere1,3, B Vandendorpe1,3, A Van Hecke1,3.   

Abstract

Non-adherence and non-persistence in breast cancer patients taking antihormonal therapy (AHT) is common. However, the complex patterns and dynamics of adherence and persistence are still not fully understood. This study aims to give insight into the process of (non-)adherence and (non-)persistence by researching influencing factors and their interrelatedness in breast cancer patients taking AHT by means of a qualitative study with semi-structured interviews. The sample consisted of 31 breast cancer patients treated with AHT. Purposive and theoretical sampling and the constant comparison method based on a grounded theory approach were used. Expectations regarding the impact of AHT, social support from family and friends, and recognition from healthcare professionals were found to influence the process of non-adherence and non-persistence. The results of this study can help healthcare professionals understand why breast cancer patients taking AHT do not always adhere to or persist in taking the therapy and may facilitate patient-tailored interventions.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  adherence; antihormonal therapy; influencing factors; persistence; process; qualitative study

Mesh:

Substances:

Year:  2015        PMID: 26059246     DOI: 10.1111/ecc.12339

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  6 in total

1.  Adherence to Oral Targeted Anti-Lung Cancer Therapy: A Qualitative Interview Study.

Authors:  Huiyue Zhou; Xin Wang; Dan Yu; Ruofei Du; Huaisong Wang; Jizhe Zhu; Haoning Zhang; Changying Chen; Tao Wang
Journal:  Patient Prefer Adherence       Date:  2022-04-11       Impact factor: 2.314

2.  Both "Vitamin L for Life" and "One Milligram of Satan": A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer.

Authors:  Kirsti I Toivonen; Devesh Oberoi; Kathryn King-Shier; Katherine-Ann L Piedalue; Joshua A Rash; Linda E Carlson; Tavis S Campbell
Journal:  Curr Oncol       Date:  2021-07-05       Impact factor: 3.677

3.  Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study.

Authors:  Yiqi Pan; Sarah R Heisig; Pia von Blanckenburg; Ute-Susann Albert; Peyman Hadji; Winfried Rief; Yvonne Nestoriuc
Journal:  Breast Cancer Res Treat       Date:  2018-01-12       Impact factor: 4.872

4.  Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.

Authors:  Leah K Lambert; Lynda G Balneaves; A Fuchsia Howard; Stephen K Chia; Carolyn C Gotay
Journal:  BMC Cancer       Date:  2018-07-11       Impact factor: 4.430

5.  Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions.

Authors:  Brittany Humphries; Stéphanie Collins; Laurence Guillaumie; Julie Lemieux; Anne Dionne; Louise Provencher; Jocelyne Moisan; Sophie Lauzier
Journal:  Pharmacy (Basel)       Date:  2018-06-09

6.  Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland - a qualitative study.

Authors:  Aline Bourdin; Julie Dubois; Rose-Anna Foley; Myriam Schluep; Olivier Bugnon; Jérôme Berger
Journal:  BMC Health Serv Res       Date:  2020-05-14       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.